東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Obesity, diabetes and inflammation =...

Avtanski, Dimiter.

Linked to FindBook

Google Book

Amazon

博客來

Obesity, diabetes and inflammation = molecular mechanisms and clinical management /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Obesity, diabetes and inflammation/ edited by Dimiter Avtanski, Leonid Poretsky.
Reminder of title:	molecular mechanisms and clinical management /
other author:	Avtanski, Dimiter.
Published:	Cham :Springer International Publishing : : 2023.,
Description:	viii, 234 p. :ill., digital ;24 cm.
[NT 15003449]:	Inflammation: Pathogenesis and Biological Markers -- Obesity and Inflammation -- Inflammation and Diabetes Mellitus -- Diabetes, Obesity, and Oxidative stress -- Advanced Glycation End-Products and Diabetes -- Genetic and Epigenetic Basis of Obesity-Induced Inflammation and Diabetes -- Inflammation and Vascular Pathologies -- Environmental and Lifestyle Factors Influencing Inflammation and Type 2 Diabetes Onset -- Inflammation in Pregnant Women with Obesity and Gestational Diabetes -- Potential Pharmaceutical and Non-Pharmaceutical Approaches to Obesity and Diabetes: Focus on Inflammation.
Contained By:	Springer Nature eBook
Subject:	Obesity - Complications. -
Online resource:	https://doi.org/10.1007/978-3-031-39721-9
ISBN:	9783031397219

Obesity, diabetes and inflammation = molecular mechanisms and clinical management /
Obesity, diabetes and inflammationmolecular mechanisms and clinical management /[electronic resource] :edited by Dimiter Avtanski, Leonid Poretsky. - Cham :Springer International Publishing :2023. - viii, 234 p. :ill., digital ;24 cm. - Contemporary endocrinology,2523-3793. - Contemporary endocrinology..

Inflammation: Pathogenesis and Biological Markers -- Obesity and Inflammation -- Inflammation and Diabetes Mellitus -- Diabetes, Obesity, and Oxidative stress -- Advanced Glycation End-Products and Diabetes -- Genetic and Epigenetic Basis of Obesity-Induced Inflammation and Diabetes -- Inflammation and Vascular Pathologies -- Environmental and Lifestyle Factors Influencing Inflammation and Type 2 Diabetes Onset -- Inflammation in Pregnant Women with Obesity and Gestational Diabetes -- Potential Pharmaceutical and Non-Pharmaceutical Approaches to Obesity and Diabetes: Focus on Inflammation.

Obesity is a worldwide epidemic that affects half a billion people. It has been estimated that, if current trends continue, by 2050, 60% of men and 50% of women worldwide will be obese. Hypertrophy and hyperplasia of white adipose tissue caused by overweight and obesity lead to a chronic inflammatory state, which results in impaired insulin sensitivity and the development of diabetes. Currently, the number of people affected by diabetes globally exceeds 400 million (rising more rapidly in low- and middle-income countries) In 2019, diabetes was the ninth leading cause of mortality, with an estimated 1.5 million direct deaths. This book provides a comprehensive overview of the relationship between inflammation, obesity, and diabetes. It focuses on the pathogenesis and biological mechanisms of obesity, the interaction between adipose tissue and the immune system, the role of genetic and environmental factors, the progression of cardiovascular complications, and the association of obesity and inflammation with type 1 and type 2 diabetes, as well as gestational diabetes. This volume also includes practical recommendations for preventing and managing these conditions using both lifestyle modifications and pharmacological interventions. Written by experts in the field, Obesity, Diabetes and Inflammation: Molecular Mechanisms and Clinical Management addresses the role of inflammation in both obesity and diabetes, its effect on vascular and non-vascular pathologies, oxidative stress, genetics, and epigenetics. This text aims to be a valuable resource for researchers, clinicians, and students of medicine at all levels.

ISBN: 9783031397219

Standard No.: 10.1007/978-3-031-39721-9doiSubjects--Topical Terms:

916038
Obesity
--Complications.

LC Class. No.: RC628

Dewey Class. No.: 616.398

Obesity, diabetes and inflammation = molecular mechanisms and clinical management /
LDR:03292nmm a2200337 a 4500 001 2334855
003 DE-He213
005 20230926195749.0
006 m d
007 cr nn 008maaau
008 240402s2023 sz s 0 eng d
020 $a 9783031397219 $q (electronic bk.)
020 $a 9783031397202 $q (paper)
024 7 $a 10.1007/978-3-031-39721-9 $2 doi
035 $a 978-3-031-39721-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC628
072 7 $a MJG $2 bicssc
072 7 $a MED027000 $2 bisacsh
072 7 $a MJG $2 thema
082 0 4 $a 616.398 $2 23
090 $a RC628 $b .O12 2023
245 0 0 $a Obesity, diabetes and inflammation $h [electronic resource] : $b molecular mechanisms and clinical management / $c edited by Dimiter Avtanski, Leonid Poretsky.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a viii, 234 p. : $b ill., digital ; $c 24 cm.
490 1 $a Contemporary endocrinology, $x 2523-3793
505 0 $a Inflammation: Pathogenesis and Biological Markers -- Obesity and Inflammation -- Inflammation and Diabetes Mellitus -- Diabetes, Obesity, and Oxidative stress -- Advanced Glycation End-Products and Diabetes -- Genetic and Epigenetic Basis of Obesity-Induced Inflammation and Diabetes -- Inflammation and Vascular Pathologies -- Environmental and Lifestyle Factors Influencing Inflammation and Type 2 Diabetes Onset -- Inflammation in Pregnant Women with Obesity and Gestational Diabetes -- Potential Pharmaceutical and Non-Pharmaceutical Approaches to Obesity and Diabetes: Focus on Inflammation.
520 $a Obesity is a worldwide epidemic that affects half a billion people. It has been estimated that, if current trends continue, by 2050, 60% of men and 50% of women worldwide will be obese. Hypertrophy and hyperplasia of white adipose tissue caused by overweight and obesity lead to a chronic inflammatory state, which results in impaired insulin sensitivity and the development of diabetes. Currently, the number of people affected by diabetes globally exceeds 400 million (rising more rapidly in low- and middle-income countries) In 2019, diabetes was the ninth leading cause of mortality, with an estimated 1.5 million direct deaths. This book provides a comprehensive overview of the relationship between inflammation, obesity, and diabetes. It focuses on the pathogenesis and biological mechanisms of obesity, the interaction between adipose tissue and the immune system, the role of genetic and environmental factors, the progression of cardiovascular complications, and the association of obesity and inflammation with type 1 and type 2 diabetes, as well as gestational diabetes. This volume also includes practical recommendations for preventing and managing these conditions using both lifestyle modifications and pharmacological interventions. Written by experts in the field, Obesity, Diabetes and Inflammation: Molecular Mechanisms and Clinical Management addresses the role of inflammation in both obesity and diabetes, its effect on vascular and non-vascular pathologies, oxidative stress, genetics, and epigenetics. This text aims to be a valuable resource for researchers, clinicians, and students of medicine at all levels.
650 0 $a Obesity $x Complications. $3 916038
650 0 $a Diabetes $x Complications. $3 834524
650 0 $a Inflammation. $3 662994
650 1 4 $a Endocrinology. $3 610914
700 1 $a Avtanski, Dimiter. $3 3666803
700 1 $a Poretsky, Leonid. $3 1086935
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Contemporary endocrinology. $3 1566840
856 4 0 $u https://doi.org/10.1007/978-3-031-39721-9
950 $a Medicine (SpringerNature-11650)